ULTRASOUND AGAINST CHEMOTHERAPY-INDUCED ALOPECIA: A NEW HOPE FOR PATIENTS
Taxanes are among the most effective chemotherapy drugs, but their effects are not limited to tumor cells. The rapidly dividing cells of hair follicles are particularly vulnerable, which is why alopecia develops in most patients and remains one of the most distressing treatment-related adverse effects. Researchers are looking for ways to protect hair without compromising the effectiveness of cancer therapy — from scalp cooling to cyclin-dependent kinase inhibitors. One emerging approach is short-term exposure to low-intensity ultrasound, which may temporarily disrupt drug-induced rigid microtubules and thereby eliminate their toxic effect on follicular cells. Read the full story in our editorial feature.